期刊文献+

煤工尘肺壹期患者血清IL-17A、IL-17F和IL-22水平变化 被引量:1

Changes of IL-17A,IL-17F and IL-22 levels in patients with stageⅠcoal workers' pneumoconiosis
原文传递
导出
摘要 目的探讨血清白细胞介素(IL)-17A、IL-17F和IL-22在煤工尘肺(CWP)壹期患者中的变化及作用。方法用酶联免疫吸附双抗体夹心法检测95例CWP壹期患者(CWP组)[其中52例单纯CWP患者,43例CWP并发症患者(分别并发慢性支气管炎、肺气肿、慢性阻塞性肺疾病)]、44例健康井下接尘矿工(接尘对照组)和37例井上健康人(正常对照组)血清中IL-17A、IL-17F和IL-22水平。结果与正常对照组和接尘对照组比较,CWP组血清IL-17A和IL-22均升高,差异均有统计学意义(P<0.05),IL-17F差异无统计学意义(P>0.05);单纯CWP患者与3种CWP并发症患者血清IL-17A、IL-17F和IL-22水平比较,差异均无统计学意义(P>0.05);CWP组IL-17A与IL-17F呈低度正相关(相关系数=0.298,P=0.032)。结论 IL-17A、IL-17F和IL-22与CWP壹期的发生发展有关,检测IL-17A和IL-22可能对协助CWP诊断有一定参考价值。
出处 《中国职业医学》 CAS 北大核心 2013年第1期50-51,54,共3页 China Occupational Medicine
  • 相关文献

参考文献10

  • 1LIU F,WENG D,CHEN Y. Depletion of CD4+ CD25+Foxp3 + regulatory T cells with anti-CD25 antibody may exacerbate the 1,3-β-glucan-induced lung inflammatory response in mice[J].Archives of Toxicology,2011,(11):1383-1394.
  • 2OUYANG W,KOLLS J K,ZHENG Y. The biological functions of T helper 17 cell effector cytokines in inflammation[J].Immunity,2008,(04):454-467.doi:10.1016/j.immuni.2008.03.004.
  • 3HARRINGTON L E,HATTON R D,MANGAN P R. Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nature Immunology,2005,(11):1123-1132.
  • 4MI S,LI Z,YANG H Z. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and-independent mechanisms[J].Journal of Immunology,2011,(06):3003-3014.
  • 5LO RE S,DUMOUTIER L,COUILLIN I. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis[J].Journal of Immunology,2010,(11):6367-6377.
  • 6吴静,徐建,张映铭,王彩英.矽肺患者血清IL-17检测的临床意义[J].放射免疫学杂志,2009,22(6):623-625. 被引量:10
  • 7VON VIETINGHOFF S,LEY K. IL-17A controls IL-17F production and maintains blood neutrophil counts in mice[J].Journal of Immunology,2009,(02):865-873.
  • 8SIMONIAN P L,WEHRMANN F,ROARK C L. γδ T cells protect against lung fibrosis via IL-22[J].Journal of Experimental Medicine,2010,(10):2239-2253.
  • 9WHITTINGTON H,ARMSTRONG L,UPPINGTON K M. In terleukin-22:a potential immunomodulatory molecule in the lung[J].American Journal of Respiratory Cell and Molecular Biology,2004,(02):220-226.doi:10.1165/rcmb.2003-0285OC.
  • 10DI STEFANO A,CARAMORI G,GNEMMI I. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients[J].Clinical and Experimental Immunology,2009,(02):316-324.

二级参考文献9

  • 1李庆,李廷,祁新兰.煤工尘肺患者血清TNF-α、sIL-2R、IL-6和IL-8检测的意义[J].中国工业医学杂志,2006,19(1):11-12. 被引量:21
  • 2Zhai R, Ge X, Li H, et al. Differences in cellular and irdtammatory cytokine profiles in the bronchoalveolar lavage fluid in bagassosis and silicesis[J]. Am J Ind Med, 2004,46:338-344.
  • 3白明,李元桂,主译.现代肺部疾病诊断与治疗[M].第1版.北京:人民卫生出版社,2006,2790.
  • 4Kolls JK, Kanaly ST, Ramsay AJ. Interleukin-17 : an emerging role in lung inflammation[J]. Am J Respir Cell Mol Biol, 2003,28: 9-11.
  • 5Larsson R. Rocksen D, Lilliehook B, et al. Dose-dependent activa- tSon of lymphocytes in endotoxin-induced airway inflammation[ J]. Infect Immun, 2000,68: 6962-6969.
  • 6Escotte S, Tabary O, Dusser D, et al. Fluticasone reduces 132-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway[J]. Eur Respir J, 2003, 21:574-581.
  • 7Shen N, He B, Wang J, et al. Significance of anti-interleukin-17 antibodies to airway inflammation in cigarette smoke-induced COPD in mice [J]. Am J Respir Crit Care Med, 2009,179: A2955.
  • 8Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines[ J ]. J Allergy Clin Immunol, 2001,108: 430-438.
  • 9Hnizdo E and Vallyathan V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence[ J]. Occup Environ Med, 2003, 60: 237-243.

共引文献9

同被引文献7

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部